CLabenz

[International Society for Hepatic Encephalopathy @ISHENliver]

We are pleased to announce that registration for ISHEN2025 is now open!

https://t.co/53qMDcaZIp

We are accepting late breaking abstracts

https://t.co/FuNuv9P4SZ

NOTE: There is very limited space. Registration will be open until full capacity

👉 Register today!

[Hepatology Communications @HepCommJournal]

🚨 #GIHepFellowshipBootcamp is heating up with these 🔥 📑s on #HepaticEncephalopathy 🧠

⭐️ Testing for CHE‼️
⭐️ Risk factors for OHE‼️
⭐️ Preventing OHE‼️
⭐️ ⭐️ Treating HE ‼️ 💊 💩

https://t.co/pQj0jDo7LJ

https://t.co/6LRdwlhQdd

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

📄 Full paper: https://t.co/bxrUqnZB7P

📚 Related paper challenging the 24h albumin new rule: https://t.co/xQ5NxuKZGY

#EASL2025

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

💉 Albumin duration & AKI response in cirrhosis
Eva M. Schleicher (Mainz) – #EASL2025
🕒 24h albumin new rule questioned
🏆 EASL AKI response definition wins
📈 20% of 24h NR improved at 48h
⚖️ Early vs late responders: Same mortality
🚨 Cr ↑ >16% @24h → terlipressin!
👇

[EASLnews @EASLnews]

Today’s #readoftheweek📚discusses QuickStroop, which is a rapid screening tool to identify patients at risk for PHES-MHE, especially in patients below 60 years of age.
Read here this @JHEP_Reports article: https://t.co/eJLIgggDt3
🙏@c_labenz @SJGairing @kaps_leonard @EvSchleicher @Maria_M_Gabriel @HeinerWedemeyer @b_maasoumy et al.

#LiverTwitter #LiverX

[JHEP Reports @JHEP_Reports]

❗QuickStroop for screening for minimal hepatic encephalopathy in patients with #cirrhosis

🔓#OpenAccess at 👉https://t.co/eooioq6GA1

#LiverTwitter

[CLabenz @c_labenz]

@ebtapper Same here!

[Mattias Mandorfer @MattiasMandorf1]

Non-Invasive CSPH Estimated Risk (NICER) model including @Echosens SSM by VCTE at 100Hz
👉Developed (2020-2022) & validated (2023) in contemporary pts.
👉Outperforms ANTICIPATE(-NASH): AUC consistently >0.9.
👉Well-calibrated.
👉Sets a new standard IMHO.

#LiverTwitter
🔗👇

[Patty Pringle Bloom, M.D. @BloomPringle]

Thrilled to have this work out in @HEP_Journal !

Short version:
The problem - it’s hard to diagnose minimal HE or predict future overt HE in clinic

What we found - automated speech analysis can do both

[roypounder.apt @APandT]

"No value of non-selective beta-blockers after TIPS-insertion" published 'open access' at https://t.co/ae68JsAMhg
#livertwitter #TIPS

[Elliot Tapper @ebtapper]

WHAT'S AT STEAK IN NUTRITION FOR HEPATIC ENCEPHALOPATHY?

No one had more fun than me and @c_labenz writing this editorial: https://t.co/hTcfz6lSmL

On @JasmohanBajaj trial of meat vs veg burgers and ammonia: https://t.co/QLiSX74MoC

[Maasoumy_liverlab @Maasoumy_lab]

Today @EASLnews, Martin Kabelitz presents his poster about the impact of #TIPS on frailty:

💪 Frailty has the potential to improve after TIPS insertion

🏋🏽 Especially patients with a high degree of frailty show improvement

SAT-090 #EASL2024

[Mattias Mandorfer @MattiasMandorf1]

@mathiasjachs & the Non-Invasive CSPH Estimated Risk (NICER) model based on a contemporary cohort integrating SSM-100Hz 👏

👉 Developed in SLD & 🦠 suppression/cure
👉 Improved discrimination & calibration.
👉 It's just the NICER model, I guess! 😜

Thanks @BavenoCoop!

[Patty Pringle Bloom, M.D. @BloomPringle]

Brilliant State of the Art talk by @dthabut on hepatic encephalopathy 🤩

Love that HE is getting this spotlight @EASLnews

As the Professor stated: HE is the worst complication of cirrhosis

We have a lot of work to do to improve this for our patients

[Elliot Tapper @ebtapper]

1+ 1 = 3
Lactulose + Rifaximin = Reduced episodes of hepatic encephalopathy
https://t.co/J7wl1CHyAx
@HepCommJournal

[Elliot Tapper @ebtapper]

There is no stepwise increase in the risk of encephalopathy with worsening psychometric scores in this international study

https://t.co/0yp1feSUQt

@HepCommJournal @SJGairing @BloomPringle @c_labenz

[Jasmohan Bajaj @JasmohanBajaj]

🔑Are all proteins🟰 for ammoniagenesis? No!
🔑Can one meal change affect ⬇️#ammonia in #cirrhosis? Yes!
✅our #RCT where 1⃣ meal change from 🥩to 🌱/🌿-based was enough to⬇️#ammonia !
🔑Impt because replacing full diets⛔️
🔑metabolomic changes
@ACG_CTG ⤵️
https://t.co/r3JeqCLQlY

[JHEP Reports @JHEP_Reports]

🟪NEW Article in press❕

Proton pump inhibitor use and risk of hepatic encephalopathy: a multicenter study

🔓#OpenAccess at 👉https://t.co/fQiSsctkmJ

#LiverTwitter
#HepaticEncephalopathy

[MetteMunkLauridsen @MMLauridsen]

Are you busy with #hepatology clinical work?
Check out the clinical care points in this short and concise review on the cerebral effects of #cirrhosis and #portalhypertension from a group of @ISHENliver members.
Out now in Clinics in #LiverDisease. 👇
https://t.co/s8UH2Bc3RD

[CLabenz @c_labenz]

Grateful for an amazing team effort! @SJGairing @MontagneseSara @BloomPringle @MMLauridsen @jumarquardt @ISHENliver @JHEP_Reports

[CLabenz @c_labenz]

Is PPI use associated with HE? Our multicenter study says no 🚫
✅1160 patients with PHES at baseline
🚫no association between PPI use and MHE or OHE development
🚫>70% without an indication for a PPI prescription❗️

👉read the study here: https://t.co/uU9TGhatmI